Markets
Nikkei 225
27,977.15
▼ -37.87 / -0.14%
SSE Composite
3,516.30
IBOVESPA
121,193.75
▲ +492.77 / +0.41%
Straits Times
3,165.49
▼ -17.31 / -0.54%
BMV IPC
51,490.94
▲ +441.25 / +0.86%
Dow Jones
35,515.38
▲ +15.53 / +0.04%
DAX 30
15,977.44
▲ +39.93 / +0.25%
BSE SENSEX
55,437.29
▲ +593.31 / +1.08%
FTSE 100
7,218.71
▲ +25.48 / +0.35%
JSE Top 40
63,269.04
▼ -7.94 / -0.01%
Market News
- Dow Jones: The Dow Jones Industrial Average seems to keep achieving record highs, as seen on last Friday’s close.
- FTSE 100: Europe’s most important indices kept rallying Friday achieving ten straight sessions of gains.
Last Week’s Highlights
European stocks gain for ten sessions in a row
European markets kept rallying last week, owing to a solid earnings season. Friday marked a record as the tenth trading session in a row to set gains for Eurozone stocks. Even though exports in the region have not recovered entirely from the pandemic; The banking, apparel, and insurance industries lead the gains. Experts say the bullish trend may not remain long term but are not ready to go negative on European stocks and securities.
FDA approves booster shots for some patients
Although Pfizer and Moderna never claimed or announced publicly that they submitted a request to the FDA for approval of booster shots or third doses; The U.S Food and Drug Administration announced before midnight on Thursday that it had updated the emergency approval for coronavirus vaccines to include a third dose for patients with organ transplants or other conditions that may be considered to have a “similar level of immunocompromise.” After the announcement, Pfizer stocks gained 2% after hours.
Coming Up This Week
Delta variant slashes China’s growth forecasts
After the spread of the Delta variant caused more than 1000 infections around China, the government has revived its extreme zero-covid policies. These policies, which include new quarantine measures in many areas and travel restrictions, have proven to be effective in keeping the virus at bay. However, these also threaten to damage the already precarious recovery of the Chinese economy. Experts at Goldman Sachs have slashed the GDP growth expectations to 2.3% from a much higher 5.8%,
UK Authorities in bid to force Facebook to sell Giphy
Facebook may be forced to renounce control of GIF platform Giphy over concerns from the UK’s Competition and Market Authority. On Tuesday, the regulatory agency noted that the acquisition of Giphy by Facebook might damage competition in the social media and advertising industry. In addition, in a provisional finding, the UK regulators noted that Facebook might restrict third-party platforms’ access to Giphy content. Experts consider the finding a red flag for any tech giant that expects to expand in this regulatory climate.
More Things to Sip On…
E-Commerce company Wish’s stock tanks 20% as demand growth slows.
EV maker NIO’s earnings grow more than 127% in a year.
Disney Corporation’s earnings are magic, and stock is up 5%
Google will cut salaries for workers who decide to work remotely.
How to pay off debt (while prioritizing saving)
There is no one-size fits all answer. However, the options to pay off debt and saving are not, and should not, be mutually exclusive.
Bull and Bear Markets: How to tame these beasts
As long as you understand how the bull and bear markets work, there is anything for long-term passive investors to get too worked up about.
“Successful investing is about managing risk, not avoiding it.”
– Benjamin Graham –
Disclaimer
All market information provided was collected in the afternoon of August 13, 2021. The purpose of NewsFlight is to summarize and make accessible information on a variety of topics within the world of investing and personal finance, and thus cannot be considered formal research or reports. All sources utilized to compile the NewsFlight newsletter are considered trustworthy by the FlexInvest team. FlexInvest Limited is not affiliated with and does not receive remuneration from the news sources used to compile NewsFlight. As well, any images or logos incorporated into the NewsFlight newsletter are not necessarily property of FlexInvest and may solely be included to provide context for the news covered. NewsFlight should not be taken as advice to sell or buy securities or to make any investment. When investing in securities or other financial products, there is always the potential to lose money or asset value. FlexInvest recommends that its users consider their investment objectives and risks before investing. Additionally, any projections or analysis made by authors of NewsFlight cannot be considered as a promise of future trends or returns. Opinions expressed in News Flight are not representative of FlexInvest Limited.
